ECM
AMPE

Element Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Element Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-284
Closed -$290K – 1062
2018
Q1 		$290K Buy
+284
New +$238K 0.01% 494
2017
Q3 		– Sell
-968
Closed -$151K – 114
2017
Q2 		$151K Buy
+968
New +$196K 0.03% 114

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Element Capital Management's AMPE Position: Q2 2018 in Review

Element Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 284 shares — an estimated $290K sold.

Element Capital Management first reported a position in AMPE in Q2 2017 and held it in 2 quarters. The position peaked at $290K in Q1 2018. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Element Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 284 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $290K.
  • Element Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2017 and held it in 2 quarters.
  • Element Capital Management's Ampio Pharmaceuticals Inc. position peaked at $290K in Q1 2018.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.